drugset / Trial / NCT01902524

Efficacy and Safety Study of Fentanyl Transdermal Patch for Treatment of Chronic Pain

NCT01902524 ↗

Phase 4 Completed 65 enrolled Janssen Korea, Ltd., Korea
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to confirm effectiveness and safety of fentanyl transdermal patch Durogesic® D-Trans for treatment of chronic pain in participants with chronic non-cancer pain.

Timeline

Start
2005-10
Primary completion
2006-11
Completion
2006-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Fentanyl-TTS Unknown 12.5 ug Other

Indications